Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- 2023-08-15
- Systematic Review · n = 546
- Reviews in cardiovascular medicine 24(8)
- Xinmin Li
- Junzi Long
- Qian Gao
- Mengyang Pan
- Jing Wang
- Fangjie Yang
- Yasu Zhang
- PubMed: 39076715
- DOI: 10.31083/j.rcm2408234
- High evidence
Nattokinase supplementation significantly reduced systolic blood pressure (MD = -3.45, 95% CI: -4.37 to -2.18, p < 0.00001)
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- relatively high total dosage